151 related articles for article (PubMed ID: 10882169)
1. Synthetic peptide mimics of a predicted topographical interaction surface: the cytochrome P450 2B1 recognition domain for NADPH-cytochrome P450 reductase.
Omata Y; Dai R; Smith SV; Robinson RC; Friedman FK
J Protein Chem; 2000 Jan; 19(1):23-32. PubMed ID: 10882169
[TBL] [Abstract][Full Text] [Related]
2. Mechanism-based inactivation of cytochrome P450 2B1 by 2-ethynylnaphthalene: identification of an active-site peptide.
Roberts ES; Hopkins NE; Alworth WL; Hollenberg PF
Chem Res Toxicol; 1993; 6(4):470-9. PubMed ID: 8374044
[TBL] [Abstract][Full Text] [Related]
3. Effect of 17-alpha-ethynylestradiol on activities of cytochrome P450 2B (P450 2B) enzymes: characterization of inactivation of P450s 2B1 and 2B6 and identification of metabolites.
Kent UM; Mills DE; Rajnarayanan RV; Alworth WL; Hollenberg PF
J Pharmacol Exp Ther; 2002 Feb; 300(2):549-58. PubMed ID: 11805216
[TBL] [Abstract][Full Text] [Related]
4. Effects of benzyl isothiocyanate on rat and human cytochromes P450: identification of metabolites formed by P450 2B1.
Goosen TC; Mills DE; Hollenberg PF
J Pharmacol Exp Ther; 2001 Jan; 296(1):198-206. PubMed ID: 11123381
[TBL] [Abstract][Full Text] [Related]
5. Effects of beta-ionone on the expression of cytochrome P450s and NADPH-cytochrome P450 reductase in Sprague Dawley rats.
Jeong TC; Gu HK; Chun YJ; Yun CH; Han SS; Roh JK
Chem Biol Interact; 1998 Jul; 114(1-2):97-107. PubMed ID: 9744558
[TBL] [Abstract][Full Text] [Related]
6. Role of lysine and arginine residues of cytochrome P450 in the interaction between cytochrome P4502B1 and NADPH-cytochrome P450 reductase.
Shen S; Strobel HW
Arch Biochem Biophys; 1993 Jul; 304(1):257-65. PubMed ID: 8323289
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of monomeric reconstituted and membrane microsomal monooxygenase systems of the rabbit liver. I. Properties of NADPH-cytochrome P450 reductase and cytochrome P450 LM2 (2B4) monomers.
Kanaeva IP; Dedinskii IR; Skotselyas ED; Krainev AG; Guleva IV; Sevryukova IF; Koen YM; Kuznetsova GP; Bachmanova GI; Archakov AI
Arch Biochem Biophys; 1992 Nov; 298(2):395-402. PubMed ID: 1416970
[TBL] [Abstract][Full Text] [Related]
8. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by 2-phenyl-2-(1-piperidinyl)propane.
Chun J; Kent UM; Moss RM; Sayre LM; Hollenberg PF
Drug Metab Dispos; 2000 Aug; 28(8):905-11. PubMed ID: 10901699
[TBL] [Abstract][Full Text] [Related]
9. Interaction between NADPH-cytochrome P-450 reductase and hepatic microsomes.
Yang CS; Strickhart FS; Kicha LP
Biochim Biophys Acta; 1978 May; 509(2):326-37. PubMed ID: 26401
[TBL] [Abstract][Full Text] [Related]
10. Identification of the heme adduct and an active site peptide modified during mechanism-based inactivation of rat liver cytochrome P450 2B1 by secobarbital.
He K; Falick AM; Chen B; Nilsson F; Correia MA
Chem Res Toxicol; 1996; 9(3):614-22. PubMed ID: 8728507
[TBL] [Abstract][Full Text] [Related]
11. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
[TBL] [Abstract][Full Text] [Related]
12. Changes in cytochrome P450 enzymes by 1,1-dichloroethylene in rat liver and kidney.
Hanioka N; Jinno H; Nishimura T; Ando M
Arch Toxicol; 1997; 72(1):9-16. PubMed ID: 9458185
[TBL] [Abstract][Full Text] [Related]
13. Blue light mediated photoreduction of the flavoprotein NADPH-cytochrome P450 reductase. A Förster-type energy transfer.
Müller-Enoch D
Z Naturforsch C J Biosci; 1997; 52(9-10):605-14. PubMed ID: 9373993
[TBL] [Abstract][Full Text] [Related]
14. Cytochromes P450 2B1 and P450 2B2 demethylate N-nitrosodimethylamine and N-nitrosomethylaniline in vitro.
Stiborová M; Hansíková H; Frei E
Gen Physiol Biophys; 1996 Jun; 15(3):211-23. PubMed ID: 9076504
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of monomeric reconstituted and membrane microsomal monooxygenase systems of the rabbit liver. II. Kinetic parameters of reductase and monooxygenase reactions.
Kanaeva IP; Nikityuk OV; Davydov DR; Dedinskii IR; Koen YM; Kuznetsova GP; Skotselyas ED; Bachmanova GI; Archakov AI
Arch Biochem Biophys; 1992 Nov; 298(2):403-12. PubMed ID: 1416971
[TBL] [Abstract][Full Text] [Related]
16. Engineering of proteolytically stable NADPH-cytochrome P450 reductase.
Bonina TA; Gilep AA; Estabrook RW; Usanov SA
Biochemistry (Mosc); 2005 Mar; 70(3):357-65. PubMed ID: 15823091
[TBL] [Abstract][Full Text] [Related]
17. Denitrosation of the anti-cancer drug 1,3-bis(2-chloroethyl)-1-nitrosourea catalyzed by microsomal glutathione S-transferase and cytochrome P450 monooxygenases.
Weber GF; Waxman DJ
Arch Biochem Biophys; 1993 Dec; 307(2):369-78. PubMed ID: 8274024
[TBL] [Abstract][Full Text] [Related]
18. [Effects of ethyl acetate extract of Semen Hoveniae on liver microsomal cytochrome P450 isoenzyme in rat].
Zhang H; Song J; Zhan XA; Tan Y
Zhongguo Zhong Yao Za Zhi; 2007 Sep; 32(18):1917-21. PubMed ID: 18051907
[TBL] [Abstract][Full Text] [Related]
19. A novel class of cytochrome P450 reductase redox cyclers: cationic manganoporphyrins.
Day BJ; Kariya C
Toxicol Sci; 2005 May; 85(1):713-9. PubMed ID: 15703263
[TBL] [Abstract][Full Text] [Related]
20. Molecular modeling of cytochrome P450 2B1: mode of membrane insertion and substrate specificity.
Dai R; Pincus MR; Friedman FK
J Protein Chem; 1998 Feb; 17(2):121-9. PubMed ID: 9535274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
